Product information
Chicken breast plasmalogen
Essence form
- Daily blended dose: 8mg*1 or 4mg*2
- Recommended formulation: soft capsules, etc.
*1. Recommended intake of plasmalogen = 1 mg/day
*2. Recommended intake of plasmalogen = 0.5 mg/day
| Packaging | |
|---|---|
| Content | 100 g/bag |
| Type of packaging | Aluminum pouch |
| Storage method and expiration date | |
| Storage method | Store at ≤ -15°C |
| Expiration date | Three years from date of manufacture (inclusive) (if unopened) ※ Consume immediately after opening. |
| Product name | Chicken breast plasmalogen |
|---|---|
| Generic name | Chicken breast extract |
| Description sample | Chicken breast extract, chicken breast essence |
| Main ingredients | Chicken breast/ethanol (contains eggs and chicken meat as parts of ingredients) |
| Manufacturing process | Patented manufacturing process Production method of phospholipid concentrates (Patent No. 6542408) Manufacturing method of phospholipid concentrates (Patent No. 6585749) |
| Characteristics | Yellowish brown viscous liquid with a distinct smell |
| Specification item | Essence form |
|---|---|
| Plasmalogen concentration | ≥12.5% |
| Moisture content | - |
| Viable bacteria count | ≤3000 bacteria per gram |
| Coliform group | Negative |
| Mold and yeast | ≤300 counts per gram |
| Heavy metals (as Pb) | ≤20 ppm |
| Arsenic (as As2O3) | ≤2 ppm |
Powder form
- Daily blended dose: 34mg*1 or 17mg*2
- Recommended formulation: hard capsules, granulated powder, tablet supplements, etc.
*1. Recommended intake of plasmalogen = 1 mg/day
*2. Recommended intake of plasmalogen = 0.5 mg/day
| Packaging | |
|---|---|
| Content | 500 g/bag |
| Type of packaging | Outer packing: Aluminum pouch |
| Inner packing: PE bag | |
| Packed with silica gel and deoxidizer | |
| Storage method and expiration date | |
| Storage method | Store tightly sealed in a cool dark place away from heat and moisture. |
| Expiration date | Two year from date of manufacture (inclusive) (if unopened) * Once opened, keep tightly sealed and consume as soon as possible. |
| Product name | Chicken breast plasmalogen powder |
|---|---|
| Generic name | Chicken breast extract |
| Description sample | Chicken breast extract, chicken breast essence |
| Main ingredients | Chicken breast extract/cyclic oligosaccharide, sodium citrate (contains eggs and chicken meat as parts of ingredients) |
| Manufacturing process | Patented manufacturing process Plasmalogen-containing compositions (Patent No. 6701461) |
| Characteristics | Pale yellow powder with a faint, distinct smell |
| Specification item | Powder form |
|---|---|
| Plasmalogen concentration | ≥3% |
| Moisture content | ≤10% |
| Viable bacteria count | ≤3000 bacteria per gram |
| Coliform group | Negative |
| Mold and yeast | ≤300 counts per gram |
| Heavy metals (as Pb) | ≤20 ppm |
| Arsenic (as As2O3) | ≤2 ppm |
Characteristics of chicken breast plasmalogen
Raw materials for SDGs
Our plasmalogen is made from adult chickens. Adult chickens are hens raised for egg production. Since they are raised for a longer period than broilers, their meat is tough and their use as meat is limited. Therefore, in terms of the effective utilization of adult chickens, we believe that our chicken breast plasmalogen is a useful product that meets the SDGs*. In addition, the raw materials we use are safe and secure domestically raised chickens, which enables us to ensure a stable supply of chicken breast plasmalogen.
* SDGs (Sustainable Development Goals) are international goals for a sustainable and better world by 2030, as stated in the "2030 Agenda for Sustainable Development" adopted by the UN Sustainable Development Summit held in September 2015. SDGs are consisted of 17 goals and 169 targets and pledge "Leave no one behind." through the implementation.
(Quoted from the website of the Ministry of Foreign Affairs of JAPAN SDGs Action Platform)
Listed on the Non-pharmaceutical Materials List
Chicken breast plasmalogen was added to the "non-pharmaceutical materials list" in the Ministry of Health, Labour and Welfare's "Partial Revision of the Standards on the Scope of Pharmaceuticals" notice (April 2018). A product is not deemed to be a drug unless claiming effectiveness and efficacy as a pharmaceutical agent. Therefore, it can be used safely as a food or health food product.
Support for Foods with Function Claims
Notifications for Foods with Function Claims have been accepted with the following details.
We also provide systematic reviews and other documents necessary for notification.
Functional substance: Chicken-derived plasmalogen
Recommended daily intake: 1 mg
Function claims: It has been reported that chicken-derived plasmalogen has a function to maintain “verbal memory,” the ability to remember and recall words, which is a part of the cognitive function of middle-aged and older people.
Recommended daily intake: 0.5 mg
Function claims: It has been reported that chicken-derived plasmalogen has a helpful function to maintain psychomotor speed (the ability to quickly and accurately judge visual information and take appropriate action), which is part of the cognitive function of middle-aged and older people.
Manufacturing process
Safety and Stability
Safety test
-
- Ames test
- No gene mutagenicity in the 5 indicator strains
-
- Chromosomal aberration test
- No clastogenic effect on CHL/IU cells
-
- Single-dose study
- 5 g/kg oral administration in rats; no deaths
-
- Repeat-dose study (90 days)
- 1 g/kg/day oral administration in rats; no toxicity
-
- Human feeding study (90 days)
- 800 mg/day repeated administration; no adverse events
- ①②④ Yuasa K., et al., Fundam. Toxicol. Sci., Vol.6, No.9(2019)
- ⑤ S. Kotoura, et al., Jpn Pharmacol Ther, 45 (9)(2017)
Storage test
- These test results were obtained by storing the actual raw material in powder form, and the results do not guarantee the storage stability of processed products (supplements) made with the raw material.
- Dots on the graph represent actual measurements, and the straight line is the approximate curve.